Inicio › Enfermedad de Alzheimer › Washington
Ensayos clínicos de Enfermedad de Alzheimer en Washington
17 estudios sobre Enfermedad de Alzheimer buscan participantes en Washington.
Ciudades en Washington
Texto oficial del estudio (inglés)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, Bellevue
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06887192A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
ReclutandoFase 2
Edades de 55 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- Local Institution - 1644, Seattle
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06937229Dominantly Inherited Alzheimer Network (DIAN)
- University of Washington, Seattle
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT00869817A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- EvergreenHealth, Kirkland
ReclutandoFase 2
Edades de 55 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07589595A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Northwest Clinical Research Center, Bellevue
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06585787Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Northwest Clinical Research Center, Bellevue
ReclutandoFase 2
Edades de 55 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT06847321A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- EvergreenHealth Medical Center, Kirkland
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011745A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
- Local Institution - 1644, Seattle
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011732Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia
- Fred Hutchinson Cancer Center, Seattle
ReclutandoEstudio observacionalSe aceptan voluntarios sanosIndica pago para participantes
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT06922188Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Washington Medical Center, Seattle
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- University of Washington, Seattle
ReclutandoFase 2/3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05552157A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Northwest Clinical Research Center, Bellevue
- Universal Research Group, Tacoma
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- University of Washington Medical Center, Seattle
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 jun 2026 · NCT07094516Late Onset Alzheimer's Disease
- University of Washington, Seattle
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 55 en adelante · Todos los sexos · Actualizado el 18 may 2026 · NCT05010603A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
- University of Washington, Seattle
Reclutando
Edades de 60 en adelante · Todos los sexos · Actualizado el 20 jul 2025 · NCT06411561De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.